ArticlePlant foods for human nutrition (Dordrecht, Netherlands)2025
Identification and Molecular Mechanism of Anti-Aging Low-Molecular-Weight Peptides from Quinoa Bran.
Article in Plant foods for human nutrition (Dordrecht, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The increasing burden of age-related degenerative diseases highlights the need for novel preventive strategies. Plant-derived active peptides have garnered attention due to their high bioactivity, low molecular weight, ease of absorption, minimal toxicity, and low immunogenicity. The high protein content of quinoa makes it an extremely valuable raw material for generating protein-derived bioactive peptides. In this study, based on the active peptides (QBPP) found from quinoa bran in previous research, peptide extracts with a molecular weight less than 3kD (QBPP-L) were further isolated and purified, which exhibited significant anti-aging activity both in vivo and in vitro. QBPP-L significantly downregulated the expression of aging-related markers (SA-β-Gal, p53, p21, and p16) in NIH-3T3 cells through inhibition of the p53 signaling pathway. Furthermore, it ameliorated oxidative stress (SOD, MDA, CAT) and enhanced neuroprotective effects in aged mouse models. In summary, the study highlights the anti-aging activity of QBPP-L in vitro and in vivo, suggesting that QBPP-L from quinoa bran is a promising natural bioactive ingredient with anti-aging properties, supporting its potential development for functional foods aimed at healthy aging.
Indexed as
Identifiers
41138019What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.